Which are the causes of Achondrogenesis?

Achondrogenesis is a group of rare, lethal skeletal dysplasias caused by specific genetic mutations that disrupt the development of cartilage and bone. These conditions are primarily driven by autosomal recessive or dominant mutations that impair the body's ability to produce essential collagen proteins, preventing proper skeletal formation during fetal development.

What causes Achondrogenesis?

Achondrogenesis is fundamentally a genetic disorder resulting from errors in the formation of the extracellular matrix in cartilage. Unlike conditions caused by environmental exposures, Achondrogenesis is strictly dictated by an individual's DNA. The primary cause is a failure in the structural integrity of the skeleton, which prevents the bones from hardening (ossifying) correctly while the fetus is in the womb.

Which genes are involved in Achondrogenesis?

The molecular causes of Achondrogenesis vary by subtype, as the condition is classified into distinct types (Type IA, IB, and II) based on their genetic origin. These mutations interfere with how the body synthesizes collagen or transports proteins within cells:

• Achondrogenesis Type IA and IB: These are inherited in an autosomal recessive pattern, meaning both parents must carry a copy of the mutated SLC26A2 gene.


• Achondrogenesis Type II: This is typically caused by a new (de novo) dominant mutation in the COL2A1 gene, which provides instructions for making type II collagen.

Are there environmental triggers or risk factors?

There are no known environmental, dietary, or lifestyle factors that cause Achondrogenesis. It is not caused by anything the parents did or did not do during pregnancy. While the term "risk factor" often implies lifestyle choices, in the case of Achondrogenesis, the only significant "risk" is the carrier status of the parents for recessive forms or the random occurrence of a spontaneous mutation for others.

Is the cause of Achondrogenesis fully understood?

While we have identified the specific gene mutations responsible for the different types of Achondrogenesis, researchers are still studying the complex cellular pathways involved. Current research focuses on how these protein defects lead to the rapid breakdown of cartilage, with the goal of developing future in-utero therapies. Within the DiseaseMaps.org community, 27 individuals have shared their experiences, helping researchers better understand the clinical presentation of these genetic variations.

Next steps

• Consult with a clinical geneticist to confirm the specific genetic subtype of Achondrogenesis.


• Seek genetic counseling to understand the inheritance patterns and risks for future pregnancies.


• Connect with the DiseaseMaps.org community to share experiences and access peer support.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Achondrogenesis.


• Orphanet: Rare Disease Database (ORPHA:1107).


• Online Mendelian Inheritance in Man (OMIM): Clinical synopsis of collagen-related skeletal dysplasias.


• Little People of America (LPA): Medical resources for skeletal dysplasias.